Buy & Sell Moderna, Inc. (MRNA) – Moderna, Inc. Price Today
Aura AI Summary
Key Stats
- $18.53BMarket Cap
- HealthSector
- -21.51%3M Drawdown
- $14.63BEnterprise Value
- -Dividend Yield
- 30% Buy | 70% SellTrading Activity
- 77 daysTypical Hold Time
Moderna, Inc. (MRNA) is currently valued at a market capitalization of $18.53B, with an enterprise value of $14.63B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -21.51%, reflecting recent price volatility. On average, investors hold Moderna, Inc. for approximately 77 days, indicating typical investor behavior on the platform.
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Most Recent News
Wrightbus selects Ballard's new fuel cell for 2027 hydrogen double-decker bus production
Wrightbus, a UK bus manufacturer, has chosen Ballard Power Systems to supply its latest FCmove-SC hydrogen fuel cell engine for the next-generation StreetDeck Hydroliner Gen 3.0 double-decker bus. Production is set to begin in 2027, with the new fuel...
AT&T raises prices on legacy wireless plans up to $20 with added hotspot data.
AT&T is increasing prices on its older, legacy wireless phone plans by up to $20 per month starting April 2026, while adding extra high-speed hotspot data to affected plans. The price hikes vary depending on the number of lines and plan types, with s...
Oil prices rise amid US-Iran tensions and uncertain peace talks.
Oil prices increased as investors reacted to ongoing tensions between the US and Iran. Despite reports of a potential peace agreement, President Trump warned of intensified bombing if Iran refuses to comply, keeping the market on edge. The conflict's...